Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-05-28
1983-04-19
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31165
Patent
active
043805507
ABSTRACT:
This invention provides a new opiate withdrawal use of an guanidine derivative and novel pharmaceutical compositions for such use.
REFERENCES:
patent: 3632645 (1972-01-01), Bream
Gold, M. S., et al., JAMA 243, pp. 343-346 (1980).
Chem. Abst., vol. 93, 125576u (1980).
Chem. Abst., vol. 90, 115374a, 1979.
Washton, A. M. et al., The Lancet, pp. 991 & 992, (5-2-81).
Gold, M. S. et al., The Lancet, pp. 992 & 993, (5-2-81).
Kleinlogel Horst
Theohar Carl
Borovian Joseph J.
Friedman Stanley J.
Honor Robert S.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Guanfacine in treating opiate addiction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanfacine in treating opiate addiction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanfacine in treating opiate addiction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-837097